Semanext Injection is a prescription medicine containing semaglutide, a GLP-1 receptor agonist designed for once-weekly use to manage Type 2 diabetes, support weight loss, and reduce cardiovascular risk
The public embraced it before science caught up
There are thousands more reports concerning Wegovys sister drugs, Ozempic and Rybelsus, and the generic drug, semaglutide
It is an FDA-approved appetite suppressant for people with obesity (BMI of 30 or higher) or overweight (BMI of 27 or higher) with a weight-related health condition, and should be used alongside a balanced eating plan and exercise
Compounded drugs are not technically approved by the FDA, though they are still required to meet certain conditions predetermined by the FDA
When Should You Take GLP-1 Injections for Weight Loss